Neuroone Medical Technologies (NMTC) Retained Earnings (2010 - 2026)

Neuroone Medical Technologies has disclosed Retained Earnings across 17 years of filings, most recently posting -$82.4 million for Q1 2026.

• Quarterly Retained Earnings fell 9.19% year-over-year to -$82.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$82.4 million (down 9.19% YoY) and the FY2025 annual result came in at -$78.6 million, down 4.81% from the prior year.
• Retained Earnings fell to -$82.4 million in Q1 2026, from -$80.0 million in the prior quarter.
• Across five years, Retained Earnings topped out at -$46.7 million in Q1 2022 and bottomed at -$82.4 million in Q1 2026.
• The 5-year median for Retained Earnings is -$68.9 million (2024), against an average of -$66.2 million.
• Year-over-year, Retained Earnings slumped 32.53% in 2022 and decreased 4.81% in 2025.
• Neuroone Medical Technologies' Retained Earnings stood at -$52.6 million in 2022, then dropped by 25.57% to -$66.0 million in 2023, then decreased by 10.91% to -$73.2 million in 2024, then declined by 9.35% to -$80.0 million in 2025, then slipped by 2.98% to -$82.4 million in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered -$82.4 million, -$80.0 million, and -$78.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.